725735-28-4

725735-28-4 structure
725735-28-4 structure
  • Name: Intetumumab
  • Chemical Name: Intetumumab
  • CAS Number: 725735-28-4
  • Molecular Formula:
  • Molecular Weight: 145.6 (kDa)
  • Catalog: Signaling Pathways JAK/STAT Signaling EGFR
  • Create Date: 2023-01-14 18:51:49
  • Modify Date: 2024-04-08 18:06:24
  • Intetumumab (CNTO 95) is a potent anti-EGFR monoclonal antibody that is glycoengineered for enhanced antibody-dependent cellular cytotoxicity (ADCC). Intetumumab can be used in research of cancer[1][2].

Name Intetumumab
Description Intetumumab (CNTO 95) is a potent anti-EGFR monoclonal antibody that is glycoengineered for enhanced antibody-dependent cellular cytotoxicity (ADCC). Intetumumab can be used in research of cancer[1][2].
Related Catalog
In Vitro Intetumumab (CNTO 95; 0-5 μg/mL; 20 分钟; USPC-ARK-3 细胞) 抑制整合素介导的 USPC 细胞粘附于玻璃连素底物,并抑制血清诱导的 USPC 细胞迁移[1]。
In Vivo Intetumumab (CNTO 95; 10 mg/kg; i.p.; 雄性裸大鼠) 抑制肿瘤生长,抑制 A549 肿瘤的自发肺转移,减少发生肺转移的大鼠数量和每个肺的转移病灶数量[2]。 Animal Model: Male nude rats with lung metastasis models (5-6 weeks old and 150-200 g)[2] Dosage: 10 mg/kg Administration: Intraperitoneal injection; once a week for 60 days Result: Had the total tumor response rates (CR and PR) was 33% in A549 tumor model. Developed lung metastases only 4 of 9 rats.
References

[1]. Bellone M, et, al. Expression of αV-integrins in uterine serous papillary carcinomas; implications for targeted therapy with intetumumab (CNTO 95), a fully human antagonist anti-αV-integrin antibody. Int J Gynecol Cancer. 2011 Aug;21(6):1084-90.  

[2]. Gonzalez-Nicolini V, et, al. Premedication and Chemotherapy Agents do not Impair Imgatuzumab (GA201)-Mediated Antibody-Dependent Cellular Cytotoxicity and Combination Therapies Enhance Efficacy. Clin Cancer Res. 2016 May 15;22(10):2453-61.  

Molecular Weight 145.6 (kDa)
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.